MWV Episode 76 - Jeffrey Almond - Vaccine Development

submitted by: MicrobeWorld
Dr. Jeffrey Almond began his career as an academic virologist studying influenza. Eventually Jeffrey started his own lab and began studying picornaviruses working on an oral polio vaccine strain. Following twenty years in academics including major contributions in the eradication of polio worldwide, Jeffrey transitioned into a career in industry working on vaccine development at Sanofi Pasteur. In March of 2013, Jeffrey was at the Society for General Microbiology's Spring conference to...

SPACEPOL Academic Publishers: Books This Autumn

submitted by: spnw

SPACEPOL Books This Autumn 2010 presents perhaps the only textbook to cut past the technology hype that is causing many governments and companies to struggle with technology spending decisions. Technological Revolution as Political Coup D'etat (ISBN13: 9789529950843) will be released this fall. Multidisciplinary expert and author Gunnar K. A. Njalsson talks about why policymakers, students, professors, journalists and other professionals should be interested.

Neglected disease research and development: how much are we really spending

submitted by: mparkinson
The need for new pharmaceutical tools to prevent and treat neglected diseases is widely accepted. The creation of a vaccine for HIV/AIDS, more effective diagnostics for tuberculosis (TB), and better treatments for leishmaniasis and sleeping sickness would greatly improve health in the developing world in line with the United Nations Millennium Development Goals. However, funders wishing to invest in this vitally important area currently face an information gap. There is little consensus on...
Authors: Mary Moran, Javier Guzman, Anne-laure Ropars, Alina Mcdonald, Nicole Jameson, Brenda Omune, Sam Ryan, Lindsey Wu